8-K - Windtree Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financing

Securities Issuance

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On November 25, 2025, Windtree Therapeutics,

Financing

$857.1K$450.0K$150.0K$1.0M

3.02

Unregistered Sales of Equity Securities. The disclosure set forth under Item 3.01 relating to the 2026 Notes is hereby incorporated into this Item 3.02 by refer

Securities Issuance

9.01

Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Document 4.1 Form of Senior Convertible Promissory

Exhibits Only

Exhibits (2)

4.1

EXHIBIT 4.1

8-K

FORM 8-K